Finnigan, John P.
Newman, Jenna H.
Patskovsky, Yury
Patskovska, Larysa
Ishizuka, Andrew S.
Lynn, Geoffrey M.
Seder, Robert A. http://orcid.org/0000-0003-3133-0849
Krogsgaard, Michelle http://orcid.org/0000-0001-5006-7981
Bhardwaj, Nina http://orcid.org/0000-0003-1865-4187
Article History
Received: 13 January 2023
Accepted: 26 February 2024
First Online: 8 March 2024
Competing interests
: J.P.F., J.N., Y.P., L.P. and R.A.S. declare no competing interests. A.S.I. and G.M.L. are employees and shareholders of Barinthus Therapeutics, which is commercializing cancer vaccines, including SNAPvaxTM. MK serves on the scientific advisory board of NexImmune, Genentech and Merck and Co. and received research support from Merck Sharp & Dohme Corp., a subsidiary of Merck and Co., Inc., Genentech, Biogen, Novartis and the Mark Foundation. N.B. serves as an advisor/board member for Apricity, BreakBio, Carisma Therapeutics, CureVac, Genotwin, Novartis, Primevax, Rome Therapeutics, Tempest Therapeutics, and as a consultant for Genentech and ATP. N.B. receives research support for Dragonfly Therapeutics, Inc., Harbour Biomed Sciences, and Regeneron Pharmaceuticals, Inc. N.B. serves on the Scientific Advisory Council/Board of the Cancer Research Institute, Duke University CHAVD, MD Anderson Cancer Centre, Parker Institute for Cancer Immunotherapy, and the American Association for Cancer Research. N.B. serves on the Grants/Research support council for the Cancer Research Institute, Ludwig Institute for Cancer Research, Melanoma Research Alliance, Leukaemia and Lymphoma Society, Pershing Square Sohn Cancer Research Alliance, and Stand Up to Cancer.